drugset / Trial / NCT00007943
Gemcitabine in Treating Patients With Advanced Colorectal Cancer
Phase 2
Completed
15 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gemcitabine in treating patients who have advanced colorectal cancer.
Timeline
- Start
- 2000-09-01
- Primary completion
- 2001-02-27
- Completion
- 2001-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | Intravenous |